(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

Converging evidence supports the potential for new treatments in addiction

What is it about?

Neuromodulation therapies are emerging that target neural and behavioral substrates of drug addiction. Whereas most previous clinical trials targeted the dorsolateral prefrontal cortex, accumulating data highlight the frontopolar cortex as a promising therapeutic target for transcranial brain stimulation in people with substance use disorders. This review provides converging pieces of evidence highlighting the importance of targeting the frontopolar area and tailoring the treatment according to interindividual variations in brain state/trait and electric field distribution patterns.

Why is it important?

Our findings provides a framework for addiction treatment using targeted neuromodulation.

Read more on Kudos…
The following have contributed to this page:
Hamed Ekhtiari
' ,"url"));